EN DE

Lycopodium Limited (LYL) Fair Value & Analysis

Industrials · AU · Market cap A$732M

LL Lycopodium Limited LYL · AU
PriceA$19.11
Fair ValueA$20.53
Upside+7.4%
Quality71/100
Watch Lycopodium Limited for free, get notified when fair value or trend changes. Watch for free
Mixed Growth
Solidly profitable · 10.3% net margin
Low debt · generates free cash flow
2.55% dividend yield
Ranks above peers (9/15)
Moderate moat 63/100
Evidence: High Range A$13.21 – A$26.13 Share as image

Fair value as of: Jul 18, 2026

From 24 valuation models · updated 23 days ago

Fair value updated Jul 18, 2026, revised from A$20.46 to A$20.53 (+0.3%) since Jun 24, 2026. Share price +1.2% over the past month.

A solid business, currently priced close to our fair value.

What matters now

  • The price sits close to our fair value, market and models broadly agree here, little valuation tension.
  • A fairly wide model range (A$13.21 to A$26.13) leaves room in how you read the outcome.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

A$19.28 A$3.21 Fair Value A$20.53 May 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 18, 2026.

How to read this chart

60‑month range A$3.21 – A$19.28 · fair‑value band A$13.21 – A$26.13 · the A$19.11 price screens below the A$20.53 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 18, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Lycopodium Limited (LYL) currently trades at A$19.11, while our model-based Fair Value estimate is A$20.53, implying the stock looks roughly 7.4% fairly valued today. The Quality Score stands at 71/100 (solid quality), in the Industrials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.

Over the trailing twelve months, Lycopodium Limited generated revenue of A$342M at a net margin of 10.3%. Revenue grew 4.6% year over year. It earns a return on equity of 24.0%. The balance sheet holds a net cash position of A$62.6M. Fundamentals as of Jul 18, 2026

Our scenario range runs from A$13.21 (bear case) to A$26.13 (bull case); at A$19.11, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades near its 52-week high and 98% above its 52-week low, currently above its 200-day average. For context, the median of 10 Industrials peers we cover trades at -45% fair-value upside, at 7%, LYL screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF A$10.74 A$15.10 A$21.01 80
Residual Income A$6.13 A$8.39 A$43.11 76
Rev-Margin DCF A$11.61 A$17.95 A$25.64 74
All 24 models by family
DCF Models
FCF DCF A$10.76 A$15.49 A$22.20 38
Owner Earnings A$13.74 A$20.07 A$29.05 31
5Y Revenue Exit A$11.61 A$18.03 A$26.44 39
5Y EBITDA Exit A$13.47 A$21.66 A$31.53 41
5Y P/E Exit A$14.57 A$23.80 A$33.89 38
10Y Revenue Exit A$10.87 A$16.39 A$24.24 36
10Y EBITDA Exit A$12.26 A$18.75 A$27.93 37
10Y P/E Exit A$12.91 A$20.14 A$29.64 35
Earnings-Based
Graham-Dodd A$7.22 A$27.34 A$37.00 54
Lynch FV A$6.63 A$9.47 A$12.31 50
PEG = 1.0 A$6.63 A$9.47 A$12.31 46
EPV A$9.05 A$10.02 A$10.82 59
Multiples
P/E Multiple A$16.73 A$22.31 A$27.89 63
P/S Multiple A$12.60 A$16.81 A$21.01 58
P/B Multiple A$12.90 A$17.20 A$21.50 55
EV/EBIT A$19.03 A$24.71 A$30.39 53
EV/EBITDA A$16.72 A$21.64 A$26.55 54
EV/Revenue A$12.58 A$17.11 A$21.65 43
Asset-Based
NCAV (Graham) A$1.91 A$2.56 A$3.82 50
Growth DCF
Growth DCF A$10.74 A$15.10 A$21.01 80
Rev-Margin DCF A$11.61 A$17.95 A$25.64 74
Economic Profit
Residual Income A$6.13 A$8.39 A$43.11 76
ROIC Compounder A$9.50 A$11.04 A$12.67 72
Growth Earnings
Growth-Adj P/E A$12.13 A$17.33 A$22.53 68

Widest divergence: DCF Models (A$18.75) versus Asset-Based (A$2.56). Highest evidence: Growth DCF (80).

Notify me when LYL reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) A$342M
Revenue growth (YoY) +4.6%
Net margin 10.3%
Return on equity 24.0%
Free cash flow A$35.2M FY2025
P/E ratio 18.0
More key figures
Operating margin 13.2%
EPS (TTM) A$0.8900
Dividend yield 2.8%
EPS growth (YoY) -27.7%
Net cash A$62.6M FY2025

Figures from reported company fundamentals · as of Jul 18, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 71/100

Of which business quality 72 · Market factors (momentum, volatility) 88

Profitability 90
Margins and returns on capital today
Quality Growth 22
Are margins and returns improving?
Cashflow 56
Earnings quality: real cash, not paper profit
Fin. Strength 99
Balance sheet, leverage, solvency risk
Investment 71
Disciplined investing over empire-building
Low Volatility 79
Calm price path (market factor)
Momentum 88
Price trend over the last 3–12 months (market factor)
52W Momentum 98
Distance to the 52-week high (market factor)
Net Issuance 82
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Lycopodium Limited provides engineering and project delivery services in the resources, rail infrastructure, and industrial processes sectors in Australia. It operates through four segments: Resources, Industrial Process, Rail Infrastructure, and Others.

Full company description

Lycopodium Limited provides engineering and project delivery services in the resources, rail infrastructure, and industrial processes sectors in Australia. It operates through four segments: Resources, Industrial Process, Rail Infrastructure, and Others. The company offers engineering and related services, including process plant and equipment, civil building works, control systems, services, and infrastructure to the mining industry; and engineering and related services to manufacturing and renewable energy facilities. It also provides asset management, engineering, architectural and project delivery services to private and public clients; and metallurgical consulting services to mineral processing community in the field of comminution, hydrometallurgy, and mineral processing design. In addition, the company offers feasibility studies and advisory; process development and optimization; process control and optimization; project management and control; construction management; commissioning and operation support; and performance assessment and improvement. The company was founded in 1992 and is headquartered in East Perth, Australia.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Lycopodium Limited reported revenue of A$334M in FY2025 versus A$158M in FY2021, a compound +20.6%/yr. Reported net income was A$42.2M in FY2025, compounding +31.3%/yr from FY2021.

Growth Quality 85/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
A$334M
Latest YoY
−3.1%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+13.4%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+10.1%
Avg. growth/yr (23Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+13.8%
Revenue +20.6%/yr
FY21 A$158M
FY22 A$229M
FY23 A$324M
FY24 A$345M
FY25 A$334M
Net income +31.3%/yr
FY21 A$14.2M
FY22 A$27.2M
FY23 A$46.8M
FY24 A$50.7M
FY25 A$42.2M
Character of growth · EPS growth decomposed (2014-2025) +33.2 % p.a.
Revenue per share +10.1 pp

of which total revenue +10.2 pp · buybacks/dilution −0.1 pp

EBIT margin +20.1 pp
Tax rate +3.1 pp
Residual (interest, one-offs) −0.2 pp

Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).

Watch LYL: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Lycopodium Limited Fair Value". https://www.fairvalue-calculator.com/stock/LYL

Peer Group

Engineering & Construction · 839 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 71 · Top 25%
Fair Value upside +7% · Above median
Return on equity (TTM) 24% · Top 25%
Return on assets 11% · Top 25%
Net margin (TTM) 10% · Top 25%
Operating margin (TTM) 13% · Top 25%
Revenue growth 5% · Above median
Dividend yield (TTM) 2.6% · Above median

Valuation Multiples vs Engineering & Construction median · lower = cheaper

P/E (TTM) 20.7× · Pricier than median
P/B 3.40× · Pricier than 75% of peers
P/S (TTM) 1.51× · Pricier than 75% of peers
P/FCF 14.7× · Pricier than 75% of peers
EV/EBITDA 9.3× · Pricier than median
PEG 2.44× · Pricier than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 43 · sector 16
FUTURE 23 · sector 17
PAST 96 · sector 26
HEALTH 100 · sector 94
DIVIDEND 51 · sector 33

Insider activity: 45/100

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Engineering & Construction stocks, each showing price versus our Fair Value estimate (as of Jul 18, 2026).

Stock Price Fair Value vs Fair Value
Larsen & Toubro Limited LT ₹3,815 ₹1,994 -48%
Samsung C&T Corporation 028260 346,000 KRW 268,779 KRW -22%
Hyundai Engineering & Construction Co 000720 99,000 KRW 63,993 KRW -35%
United Integrated Services Co 2404 1,250 TWD 925.62 TWD -26%
Samsung E&A Co 028050 42,550 KRW 44,840 KRW +5%
Rail Vikas Nigam Limited RVNL ₹232.67 ₹61.46 -74%
Daewoo Engineering & Construction Co 047040 16,240 KRW 6,507 KRW -60%
NBCC (India) Limited NBCC ₹96.32 ₹48.22 -50%
Cemindia Projects Limited CEMPRO ₹1,330 ₹730.69 -45%
KEPCO Engineering & Construction Company 052690 92,700 KRW 20,172 KRW -78%

Compare Lycopodium Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Lycopodium Limited (LYL) overvalued or undervalued?
As of Jul 18, 2026, our model estimates a fair value of A$20.53 versus a price of A$19.11, about +7% (fairly valued).
What is the fair value of LYL?
Our model-based fair value for Lycopodium Limited is A$20.53 (as of Jul 18, 2026), built from audited fundamentals. The current price is A$19.11.
What is the quality score of LYL?
Lycopodium Limited has a Quality Score of 71/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Lycopodium Limited (LYL)?
Lycopodium Limited reported trailing-twelve-month revenue of about A$342M (latest available figure, as of Jul 18, 2026).
What is the net profit margin of LYL?
The net profit margin of Lycopodium Limited is about 10.3%, meaning it keeps roughly 10.3% of revenue as net income. Based on the latest reported figures.
Does Lycopodium Limited pay a dividend?
Lycopodium Limited currently shows a dividend yield of about 2.84% relative to its recent price (as of Jul 18, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Lycopodium Limited and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.